Clinical Trial Update: Bone Response to Soy Isoflavones in Women [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bone response to soy isoflavones in women with osteopenia or osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Soy Isoflavones (isoflavones from soy)

Snippet

Sponsor: Iowa State University | Conditions: Osteopenia, Osteoporosis | Phase 2 | Status: COMPLETED